Pharmedic Pharmaceutical Medicinal JSC 2024 AR2
The report highlights Pharmedic Pharmaceutical Medicinal Joint Stock Company's performance in 2024, achieving a total revenue of VND 508.074 billion and a pre-tax profit of VND 100.313 billion, exceeding its annual plan. The company expanded its operations by establishing a new branch in Hanoi and approved the implementation of the SAP S/4HANA ERP system to enhance management capabilities. In sustainability, Pharmedic maintained its GMP-WHO compliance, received CGMP certification for cosmetics, and successfully operated its wastewater treatment system. The company also continued its community support through various charitable programs and health education initiatives.
Company: Pharmedic Pharmaceutical Medicinal JSC
Sector: Health Care
Country: Vietnam
Year: 2024
Type: AR2
Pages: 111
Pharmedic Pharmaceutical Medicinal JSC
Annual Report
The report highlights Pharmedic Pharmaceutical Medicinal Joint Stock Company's performance in 2024, achieving a total revenue of VND 508.074 billion and a pre-tax profit of VND 100.313 billion, exceeding its annual plan. The company expanded its operations by establishing a new branch in Hanoi and approved the implementation of the SAP S/4HANA ERP system to enhance management capabilities. In sustainability, Pharmedic maintained its GMP-WHO compliance, received CGMP certification for cosmetics, and successfully operated its wastewater treatment system. The company also continued its community support through various charitable programs and health education initiatives.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
Apr 18, 2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Employees